Management of the Adnexal Mass: Considerations for the Family Medicine Physician
- PMID: 35865172
- PMCID: PMC9294310
- DOI: 10.3389/fmed.2022.913549
Management of the Adnexal Mass: Considerations for the Family Medicine Physician
Abstract
Ovarian cancer is the most deadly gynecological cancer, so proper assessment of a pelvic mass is necessary in order to determine which are at high risk for malignancy and should be referred to a gynecologic oncologist. However, in a family medicine setting, evaluation and treatment of these masses can be challenging due to a lack of resources. A number of risk assessment tools are available to family medicine physicians, including imaging techniques, imaging systems, and blood-based biomarker assays each with their respective pros and cons, and varying ability to detect malignancy in pelvic masses. Effective utilization of these assessment tools can inform the care pathway for patients which present with an adnexal mass, such as expectant management for those with a low risk of malignancy, or referral to a gynecologic oncologist for surgery and staging, for those at high risk of malignancy. Triaging patients to the appropriate care pathway improves patient outcomes and satisfaction, and family medicine physicians can play a key role in this decision-making process.
Keywords: biomarkers; family medicine; multivariate index assay; ovarian cancer; pelvic mass; simple rules; ultrasound.
Copyright © 2022 Bullock, Larkin, Turker and Stampler.
Conflict of interest statement
KS has been a consultant for Aspira Women’s Health, Inc., and is currently employed by Einstein Healthcare Network. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Guideline No. 403: Initial Investigation and Management of Adnexal Masses.J Obstet Gynaecol Can. 2020 Aug;42(8):1021-1029.e3. doi: 10.1016/j.jogc.2019.08.044. J Obstet Gynaecol Can. 2020. PMID: 32736853 Review.
-
Investigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the Netherlands.BMC Cancer. 2015 Jun 26;15:482. doi: 10.1186/s12885-015-1319-5. BMC Cancer. 2015. PMID: 26111920 Free PMC article. Clinical Trial.
-
Initial evaluation and referral guidelines for management of pelvic/ovarian masses.J Obstet Gynaecol Can. 2009 Jul;31(7):668-80. doi: 10.1016/s1701-2163(16)34254-2. J Obstet Gynaecol Can. 2009. PMID: 19761648 English, French.
-
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.Am J Obstet Gynecol. 2016 Apr;214(4):424-437. doi: 10.1016/j.ajog.2016.01.007. Epub 2016 Jan 19. Am J Obstet Gynecol. 2016. PMID: 26800772
-
First International Consensus Report on Adnexal Masses: Management Recommendations.J Ultrasound Med. 2017 May;36(5):849-863. doi: 10.1002/jum.14197. Epub 2017 Mar 7. J Ultrasound Med. 2017. PMID: 28266033
Cited by
-
ReClassification of Patients with Ambiguous CA125 for Optimised Pre-Surgical Triage.Diagnostics (Basel). 2024 Mar 22;14(7):671. doi: 10.3390/diagnostics14070671. Diagnostics (Basel). 2024. PMID: 38611584 Free PMC article.
-
Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.Br J Cancer. 2024 Jun;130(10):1716-1724. doi: 10.1038/s41416-024-02644-4. Epub 2024 Apr 24. Br J Cancer. 2024. PMID: 38658783 Free PMC article.
-
O-RADS: Good Enough for Everyday Practice or a Work in Progress?Radiol Imaging Cancer. 2022 Sep;4(5):e220121. doi: 10.1148/rycan.220121. Radiol Imaging Cancer. 2022. PMID: 36178353 Free PMC article. No abstract available.
-
AI-based automated segmentation for ovarian/adnexal masses and their internal components on ultrasound imaging.J Med Imaging (Bellingham). 2024 Jul;11(4):044505. doi: 10.1117/1.JMI.11.4.044505. Epub 2024 Aug 6. J Med Imaging (Bellingham). 2024. PMID: 39114540 Free PMC article.
-
Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.JAMA Netw Open. 2023 Jul 3;6(7):e2323289. doi: 10.1001/jamanetworkopen.2023.23289. JAMA Netw Open. 2023. PMID: 37440228 Free PMC article.
References
-
- National Cancer Institute. Cancer Stat Facts: Ovarian Cancer. SEER. (2022). Available online at: https://seer.cancer.gov/statfacts/html/ovary.html (accessed on January 28, 2022).
-
- Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial. Lancet. (2021) 397:2182–93. 10.1016/S0140-6736(21)00731-5 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous